Helping to make insulin more affordable

The cost of insulin has steadily increased over time, making it one of the most costly prescription drugs on the market.

For some, these price increases may be putting the drug out of reach or causing people to make difficult — sometimes unsafe — decisions. With more than 34 million Americans currently living with diabetes and 1.5 million diagnosed every year, there needs to be a solution to help more people have access to affordable insulin.

UnitedHealthcare is committed to helping members manage their chronic conditions, like diabetes, which includes access to affordable prescriptions. Recently, UnitedHealthcare announced it will eliminate out-of-pocket costs in standard, fully insured group plans for certain preferred prescription drugs, including insulin. This new standard offering will be available to group fully insured plans, potentially as early as Jan. 1, 2023.

“High prices are a significant barrier to prescription drugs for many people, so we are using our unique capabilities to deliver savings for consumers,” said Brian Thompson, chief executive officer of UnitedHealthcare. “We are doing what we can to shield people from the prices set by pharmaceutical companies, and hope all stakeholders also will act to make prescription drugs more affordable.” 

In addition to insulin, several other drugs used to treat emergencies, such as severe allergic reactions, hypoglycemia, opioid overdoses and acute asthma attacks will also be available for eligible members at a $0 cost share. These include:

  • Epinephrine (for severe allergic reactions)
  • Glucagon (for hypoglycemia)
  • Naloxone (for opioid overdose)
  • Albuterol (for acute asthma attacks)

Insulin is a lifesaving drug for people living with diabetes, but the high cost may put many diabetics at risk. This is why strategies to improve access and affordability are critical.

Learn more about how UnitedHealthcare is helping members with diabetes.